Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Wild new cancer treatment attacks tumors with drug-filled, magnetically-guided bubbles

Add as a preferred source on Google

A new method of delivering anticancer drugs may help bypass some of the damaging effects of chemotherapy. Using magnetic micro-bubbles and ultrasonic vibrations, scientists have been able to transport and deploy drugs deep into tumor cells.

The scientists developed magnetic micro-bubbles, which were covered with magnetic nanoparticles, which were embedded with anti-cancer drugs. They injected this whole concoction into the bloodstreams of laboratory mice. The magnetization enabled scientists to steer the micro-bubbles towards tumors and, with ultrasound vibrations, maneuver them towards the tumor’s vulnerable area. Added ultrasound vibrations caused the bubbles to explode, shooting anticancer drug-carrying nanoparticles 50 cell layers deep or hundreds of micrometers into tumor tissue.

Recommended Videos

In a paper published in the journal Nature, scientists Chenjie Xu and Claus-Dieter Ohl of Nanyang Technological University (NTU Singapore) say, “Targeted drug delivery and controlled release is the ‘holy grail’ of nanomedicine.” That’s because chemotherapy drugs are indiscriminate, damaging both cancerous and healthy cells as they flow through the bloodstream. A drug’s effectiveness is also compromised once it’s absorbed and filtered by the liver and lungs. What’s left of the anticancer drug has limited effects on the tumor itself, as it’s unable to infiltrate into the tissue. The cancer cells that remain alive can multiply and cause resurgence of the disease.

Last month, Chinese and American researchers developed another innovative method to address targeted drug deliver and controlled release. With nanoparticle “cluster bombs,” a team led Jun Wang, Shuming Nie, et al. were able to sneak into tumor tissue and release chemotherapy medicine directly inside the cells. The three-staged process sees relatively large nanoparticles travel through the bloodstream, slip into the tumor’s leaky blood vessels, and discharge anticancer “bomblets” which infiltrate and attack the tumor cells. With methods like these, cancer cells can run and hide but they’ll be tracked, infiltrated, and assassinated.

Dyllan Furness
Former Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more